# GC Genome

Source: https://onco.cc/companies/gc-genome/  
OnCo record `gc-genome` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A South Korean genetic testing company that sells ai-CANCERCH, a blood test for several cancers based on DNA fragment patterns.

## Summary

GC Genome launched ai-CANCERCH in September 2023 for six cancers, built on whole-genome fragmentomics developed with KAIST (Nature Communications 2023), and announced in November 2025 a planned expansion to ten.

## Fields

- Kind: Company
- Last checked: 2026-10-29
- HQ: Yongin
- Type: diagnostics

## Notes

- The company's website could not be confirmed on 29 October 2026; the launch and expansion dates are the company's own, from its 27 November 2025 press release.

## Sources

- Bae et al., Nature Communications 2023: https://doi.org/10.1038/s41467-023-37768-3

## Connected records

- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/), [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [cfDNA fragmentomics](https://onco.cc/technologies/fragmentomics/), [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- drugs: [ai-CANCERCH](https://onco.cc/drugs/ai-cancerch/)

---
JSON: https://onco.cc/api/v1/entities/gc-genome.json